SecBot SecBot
SECBOTREPLAY Home › Report › XENE

XENE · Xenon Pharmaceuticals granted 20,200 stock options and 11,850 RSUs to…

Xenon Pharmaceuticals Inc. · PRESS-RELEASE filed Jul 2, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 1/10

PRESS-RELEASE filed Jul 2, 2026 at 16:01 ET

Xenon Pharmaceuticals granted 20,200 stock options and 11,850 RSUs to four new non-officer employees as inducement equity awards under Nasdaq Rule 5635(c)(4), with an exercise price of $60.30 per share. The grants are routine retention tools for new hires and have negligible dilutive impact relative to the company's $5.8B market capitalization.

  • Aggregate grants: 20,200 share options and 11,850 RSUs to four new non-officer employees
  • Option exercise price: $60.30 per share, equal to July 1, 2026 closing price
  • Options vest 25% at one-year anniversary, then monthly over 4 years; RSUs vest 25% annually over 4 years
  • Grants approved by Compensation Committee as inducements material to employment per Nasdaq Rule 5635(c)(4)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access